Avantel Q1FY27 Net Profit Rises 65% YoY to ₹761.77 Lakh; EBITDA Margin Expands

3 min read     Updated on 11 Jul 2026, 06:44 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Avantel reported Q1FY27 standalone net profit of ₹761.77 lakh, up from ₹46M rupees YoY, with revenue from operations at ₹7012.34 lakh versus ₹518M rupees in the prior year period. EBITDA improved to ₹191M rupees from ₹114M rupees YoY, with EBITDA margin expanding to 27.30% from 21.89%. The Board also approved key managerial appointments and remuneration revisions at its July 11, 2026 meeting.

powered bylight_fuzz_icon
45305979

*this image is generated using AI for illustrative purposes only.

Avantel Limited reported a standalone net profit of ₹761.77 lakh for the first quarter ended June 30, 2026, reflecting a strong year-on-year (YoY) growth compared to ₹46M rupees in the same quarter of the previous year. Revenue from operations for the quarter stood at ₹7012.34 lakh (₹701M rupees), up from ₹518M rupees in the corresponding quarter of the prior year. The company's total income for Q1FY27 was ₹7023.89 lakh, while revenue from operations in the preceding quarter ended March 31, 2026, was ₹6314.66 lakh.

The Board of Directors, at its meeting held on July 11, 2026, approved the unaudited standalone and consolidated financial results for the period. The results were reviewed by the Statutory Auditors and the Audit Committee. The company operates in a single segment, focusing on communications and signal processing products, and noted that its principal customer is an organization controlled by the Government of India, which influenced its decision regarding loss allowance provisions.

Financial Performance

Avantel's standalone financial results for the quarter ended June 30, 2026, reflect broad-based improvement across key metrics on both a sequential and year-on-year basis. EBITDA for the quarter came in at ₹191M rupees, compared to ₹114M rupees in Q1 of the previous year, while the EBITDA margin expanded to 27.30% from 21.89% YoY. Total expenses for the quarter were ₹5931.69 lakh, and profit before tax stood at ₹1092.20 lakh. The basic and diluted earnings per equity share (face value ₹2) stood at ₹0.29 for the quarter.

The following table summarises the standalone financial performance across reporting periods (all figures in ₹ lakh unless stated):

Particulars: Q1FY27 (30/06/2026) Unaudited Q4FY26 (31/03/2026) Audited FY26 (31/03/2026) Audited
Revenue from Operations: ₹7012.34 ₹6314.66 ₹22135.23
Total Income: ₹7023.89 ₹6423.54 ₹22380.90
Total Expenses: ₹5931.69 ₹5461.29 ₹19163.69
Net Profit for the Period: ₹761.77 ₹705.23 ₹2249.97
Earnings per Share (Basic): ₹0.29 ₹0.29 ₹0.92

The YoY performance highlights a significant improvement across key operating metrics:

Metric: Q1FY27 Q1FY26 Change (YoY)
Net Profit: ₹76M ₹46M Higher YoY
Revenue from Operations: ₹701M ₹518M Higher YoY
EBITDA: ₹191M ₹114M Higher YoY
EBITDA Margin: 27.30% 21.89% Expanded YoY

On a consolidated basis, which includes subsidiary iMeds Global Private Limited, the company reported a net profit of ₹539.46 lakh for Q1FY27, compared to ₹477.47 lakh in the previous quarter. Total consolidated revenue from operations was ₹7042.16 lakh. The subsidiary reported a net loss of ₹222.31 lakh for the quarter, which the management stated is not material to the Group.

Board Decisions and Appointments

The Board approved the revision of remuneration for Mr. Abburi Siddhartha Sagar, Executive Director (Strategy & Business Development), from ₹48.00 Lakhs per annum to ₹55 Lakhs per annum, effective July 11, 2026. Additionally, the Board approved the re-appointment of Mr. Abburi Siddhartha Sagar for a further term of five years commencing March 8, 2027, subject to shareholder approval via postal ballot.

Mr. Peddi Bala Bhaskar Rao was appointed as an Additional Director designated as Director (Operations) for a term of three years effective July 11, 2026, subject to shareholder approval. The Board also approved the re-appointment of Mr. Vyasabhattu Ramchander as an Independent Director for a second consecutive term of five years from May 6, 2027, subject to approval by a special resolution through postal ballot. The Board further reconstituted the Audit Committee, Nomination and Remuneration Committee, and Stakeholders' Relationship Committee with immediate effect.

Historical Stock Returns for Avantel

1 Day5 Days1 Month6 Months1 Year5 Years
+0.21%+0.01%+7.27%+15.20%+11.09%-7.22%

How will the company's dependence on a single government-controlled customer impact its revenue stability and order book visibility in the coming quarters?

What strategic measures are being implemented to turn around the performance of the loss-making subsidiary, iMeds Global Private Limited?

Can the expanded EBITDA margin of 27.30% be sustained throughout FY27 given the sequential increase in total expenses?

Avantel appoints Mr. Peddi Bala Bhaskar Rao as Director (Operations)

1 min read     Updated on 11 Jul 2026, 03:01 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Avantel Ltd has appointed Mr. Peddi Bala Bhaskar Rao as Director (Operations) for a three-year term and re-appointed Mr. Abburi Siddhartha Sagar and Mr. Vyasabhattu Ramchander as Executive Director and Independent Director respectively. The Board also reconstituted its key committees, including the Audit and Nomination and Remuneration Committees.

powered bylight_fuzz_icon
45307888

*this image is generated using AI for illustrative purposes only.

Avantel Ltd has appointed Mr. Peddi Bala Bhaskar Rao as Director (Operations) for a term of three years effective July 11, 2026, subject to shareholder approval. The Board of Directors also approved the re-appointment of Mr. Abburi Siddhartha Sagar as Executive Director (Strategy & Business Development) and Mr. Vyasabhattu Ramchander as Independent Director. These decisions were taken during a board meeting held on July 11, 2026.

Mr. Peddi Bala Bhaskar Rao, currently Vice President – Marketing & Customer Support, brings over 30 years of experience in RF System Design and Electronic Warfare. His appointment as an Additional Director is for a term ending July 10, 2029. Mr. Rao holds 1,41,965 equity shares, representing 0.05% of the company's share capital.

Mr. Abburi Siddhartha Sagar has been re-appointed for a further term of five years commencing March 8, 2027, and ending March 7, 2032. He holds 2,25,15,377 equity shares, or 8.47% of the company. Mr. Sagar is the son of Dr. Abburi Vidyasagar, Chairman & Managing Director, and Mrs. Abburi Sarada, Whole-Time Director & Chief Financial Officer.

Mr. Vyasabhattu Ramchander has been re-appointed as an Independent Director for a second consecutive term of five years from May 6, 2027, to May 5, 2032. His re-appointment is subject to a Special Resolution via postal ballot. Mr. Ramchander does not hold any equity shares in the company.

Consequently, the Board reconstituted the Audit Committee, Nomination and Remuneration Committee, and Stakeholders Relationship Committee with immediate effect. Mr. Vyasabhattu Ramchander will serve as Chairman of the Audit Committee, while Smt. Harita Vasireddi will chair the Nomination and Remuneration Committee.

Director Appointments and Terms

Director Designation Term Start Term End Shareholding
Mr. Peddi Bala Bhaskar Rao Director (Operations) July 11, 2026 July 10, 2029 1,41,965 (0.05%)
Mr. Abburi Siddhartha Sagar Executive Director (Strategy & Business Development) March 8, 2027 March 7, 2032 2,25,15,377 (8.47%)
Mr. Vyasabhattu Ramchander Independent Director May 6, 2027 May 5, 2032 Nil

Historical Stock Returns for Avantel

1 Day5 Days1 Month6 Months1 Year5 Years
+0.21%+0.01%+7.27%+15.20%+11.09%-7.22%

How will Mr. Rao's extensive background in Electronic Warfare influence Avantel's future product roadmap and R&D strategy?

What specific strategic growth initiatives does the company plan to pursue under Mr. Sagar's extended tenure as Executive Director?

How will the reconstituted Audit Committee, led by Mr. Ramchander, enhance the company's corporate governance standards?

More News on Avantel

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:+11.09%